General Inception Launches Igniter Europe with the support of leading institutions and venture capital firms
General Inception announces the launch of Igniter Europe, focused on building innovative companies in the field of oncology, autoimmune and rare diseases, developing novel therapeutics and leveraging disruptive technology platforms. PALO ALTO, Calif. and LYON, France, April 29, 2024... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 30, 2024 Category: Pharmaceuticals Tags: PDT Source Type: news
Monthly News Roundup - April 2024
FDA Approves First-in-Class Anktiva Plus BCG for Bladder Cancer
In April the U.S. Food and Drug Administration (FDA) approved ImmunityBio’s Anktiva (nogapendekin alfa inbakicept-pmln), a cancer immunotherapy for the treatment of patients with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2024 Category: Pharmaceuticals Source Type: news
Mayo Clinic Q & amp;A: What to know about cervical cancer
DEAR MAYO CLINIC: My mom had a pap smear recently, and the results came back as abnormal. After further testing, we were shocked when she was diagnosed with cervical cancer. She didn't have any symptoms. Now, her healthcare team is discussing surgery and medications. What should I know about her illness? As her daughter, should I be worried about myself? Most importantly, how I can support her during treatment? ANSWER: I commend you for finding… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 30, 2024 Category: Databases & Libraries Source Type: news
Red flag colour of tongue warning that can be sign of cancer or diabetes
Scientists from Harvard University say your tongue can provide information about your health. (Source: Daily Express - Health)
Source: Daily Express - Health - April 29, 2024 Category: Consumer Health News Source Type: news
Winner of $1.3B Powerball Jackpot Is an Immigrant From Laos Who Has Cancer
(SALEM, Ore.) — One of the winners of a historic $1.3 billion Powerball jackpot last month is an immigrant from Laos who has had cancer for eight years and had his latest chemotherapy treatment last week.
Cheng “Charlie” Saephan, of Portland, told a news conference held by the Oregon Lottery that he and his wife, Duanpen, would split the prize evenly with a friend who chipped in $100 to buy a batch of tickets with them, Laiza Chao. They are taking a lump sum payment, $422 million after taxes.
[time-brightcove not-tgx=”true”]
“I will be able to provide for my family and my health,&...
Source: TIME: Health - April 29, 2024 Category: Consumer Health News Authors: CLAIRE RUSH / AP Tags: Uncategorized News Desk wire Source Type: news
The cancer drugs that could improve survival rates if given to patients in the morning
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs - at the start of the day instead of after lunchtime. (Source: the Mail online | Health)
Source: the Mail online | Health - April 29, 2024 Category: Consumer Health News Source Type: news
Q & A: PIK3CA-Related Overgrowth Spectrum Q & A: PIK3CA-Related Overgrowth Spectrum
Dr Keppler-Noreuil discusses PIK3CA-related overgrowth spectrum main clinical features and management.Medscape Oncology (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 29, 2024 Category: Surgery Tags: Hematology-Oncology Commentary Source Type: news
Major Gaps in Cancer Screening at Federally Qualified Health Centers
(MedPage Today) -- Breast, cervical, and colorectal cancer screening use at federally qualified health centers (FQHCs) was substantially lower than that seen in overall general populations, according to results from a national cross-sectional study... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 29, 2024 Category: American Health Source Type: news
Call to Action: Prioritizing Cure in Lung Cancer Call to Action: Prioritizing Cure in Lung Cancer
Dr Mark Kris discusses the prioritization of cure and the impact on clinical trial design.Medscape Oncology (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 29, 2024 Category: Surgery Tags: Hematology-Oncology Commentary Source Type: news
University of Texas' MD Anderson Cancer Center expands national network to Chicago
The University of Texas MD Anderson Cancer Center's latest partnership creates a new network in Illinois that provides cancer care to residents while allowing MD Anderson to expand its clinical testing base. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 29, 2024 Category: Biotechnology Authors: Jishnu Nair Source Type: news
FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) for recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Tisotumab vedotin-tftv previously received acce (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 29, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
The 6p tablet that experts say can slash rates of cancer and heart disease
Health experts are recommending a 6p a day tablet linked to cutting cancer and heart disease (Source: Daily Express - Health)
Source: Daily Express - Health - April 29, 2024 Category: Consumer Health News Source Type: news
Hereditary Amyloidosis: 5 Things to Know Hereditary Amyloidosis: 5 Things to Know
The heterogeneity of hereditary amyloidosis can delay diagnosis and seriously affect prognosis and patient quality of life; these five things are need-to-know.Medscape Oncology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 29, 2024 Category: Neurology Tags: Hematology-Oncology Commentary Source Type: news
Diagnostics firm moves HQ to North Carolina seeking lower costs
A Swedish company focused on pancreatic cancer is setting up operations in Research Triangle Park after significantly reducing its workforce. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 29, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news
FDA Approves First Drug for WHIM Syndrome
(MedPage Today) -- The FDA approved mavorixafor (Xolremdi) capsules as the first therapy specifically for WHIM syndrome, a rare primary immunodeficiency and chronic neutropenic disorder, X4 Pharmaceuticals announced on Monday.
Caused by CXC chemokine... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 29, 2024 Category: Hematology Source Type: news
